Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

DYNDYN
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in DYNE THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 2.2M shares of DYN (DYNE THERAPEUTICS INC), worth $49.6M as of 2026-Q2. The position was increased (+54.7% shares). DYN represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$49.6M

Current Shares

2.2M

Total Value Change

+$39.1M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+54.7%
$49.6M0.0%$22.21
41
2026-Q1
Increased
1.4M
+63.5%
$26.2M0.0%$14.60
42
2025-Q4
Increased
882,922
+16.0%
$17.3M0.0%$19.20
33
2025-Q3
Increased
761,112
+48.1%
$9.6M0.0%$12.37
38
2025-Q2
Increased
513,801
+90.3%
$4.9M0.0%$9.57
42
2025-Q1
Increased
269,976
+120.1%
$2.8M0.0%$11.45
42
2024-Q4
Decreased
122,641
-58.0%
$2.9M0.0%$23.56
0
2024-Q3
Increased
291,712
+65.0%
$10.5M0.0%$35.92
41

Other major holders of DYN: FMR LLC, BlackRock, Inc., Janus Henderson Group Ltd., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used